In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor.

Journal of the American Heart Association

Volumn 1, Issue 6, 2012, Pages

  Mathison, Megumi ^a   Gersch, Robert P ^b   Nasser, Ahmed ^b   Lilo, Sarit ^b   Korman, Mallory ^b   Fourman, Mitchell ^b   Hackett, Neil ^b   Shroyer, Kenneth ^b   Yang, Jianchang ^b   Ma, Yupo ^b   Crystal, Ronald G ^b   Rosengart, Todd K ^b  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MEF2C PROTEIN, RAT; MYOGENIC FACTOR; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR 5; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR TBX5; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; ARTICLE; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; ECHOCARDIOGRAPHY; FIBROSIS; FISCHER 344 RAT; FLUORESCENT ANTIBODY TECHNIQUE; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE FUNCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; STEM CELL; TREATMENT OUTCOME;

ANGIOGENESIS; GENE THERAPY; MYOCARDIAL INFARCTION; STEM CELLS;

ANIMALS; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; FIBROSIS; FLUORESCENT ANTIBODY TECHNIQUE; GATA4 TRANSCRIPTION FACTOR; GENE TRANSFER TECHNIQUES; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; MYOGENIC REGULATORY FACTORS; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, INBRED F344; T-BOX DOMAIN PROTEINS; TRANSCRIPTION FACTORS; TRANSFECTION; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR FUNCTION;

EID: 84880316804     PISSN: None     EISSN: 20479980     Source Type: None    
DOI: 10.1161/JAHA.112.005652     Document Type: Article

References (0)